Dark

Check out our Level2View

EXAI
Exscientia Plc
stock NASDAQ

Inactive

Nov 19, 2024

4.84USD+3.198%(+0.15)1,509,851

Pre-market

0.00USD-100.000%(-4.69)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 27, 2022

08:31AM EST Expert.ai Strengthens Business Agreement with Multinational Insurance Company PR Newswire

Jan 19, 2022

06:00AM EST Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI Business Wire

Jan 7, 2022

01:01PM EST Exscientia and Sanofi Announced Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-engineered Medicines Exscientia to Receive Upfront Cash Payment of $100M From Sanofi Plus Up to $5.2B in Milestone, Regulatory Payments Benzinga

01:06AM EST Exscientia And Sanofi Establish Research Collaboration To Develop AI-driven Pipeline Of Precision-Engineered Medicines RTTNews

01:00AM EST Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered Medicines Business Wire

Dec 20, 2021

09:01AM EST The Evolution of Cyber Insurance in 2021 Through the Lens of expert.ai's PR Newswire

Nov 23, 2021

08:00AM EST Exscientia to Present at Evercore ISI 4th Annual HealthCONx Virtual Conference Business Wire

Nov 22, 2021

08:30AM EST Expert.ai Establishes North American Headquarters in Boston PR Newswire

Nov 17, 2021

04:03PM EST Exscientia Reports Q3 Sales 17.6M Up From Benzinga

04:01PM EST Exscientia Business Update for Third Quarter 2021 Business Wire

03:59AM EST Earnings Scheduled For November 17, 2021 Benzinga

Nov 10, 2021

08:00AM EST Exscientia to Report Third Quarter 2021 Financial Results on November 17, 2021 Business Wire

Oct 26, 2021

10:08AM EDT Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2021 Benzinga

07:57AM EDT B of A Securities Initiates Coverage On Exscientia with Buy Rating, Announces Price Target of $27 Benzinga

07:40AM EDT Morgan Stanley Initiates Coverage On Exscientia with Equal-Weight Rating, Announces Price Target of $25 Benzinga

06:15AM EDT Goldman Sachs Initiates Coverage On Exscientia with Buy Rating, Announces Price Target of $30 Benzinga

Oct 24, 2021

11:45AM EDT The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More Benzinga

Oct 12, 2021

08:13AM EDT The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology Benzinga

Oct 11, 2021

04:02PM EDT Exscientia Announces Publication of EXALT-1 Trial In Cancer Discovery Demonstrates First AI-Supported Functional Precision Medicine Platform To Improve Cancer Treatment Outcomes Benzinga

04:01PM EDT Publication of EXALT-1 Trial in Cancer Discovery Demonstrates First AI-Supported Functional Precision Medicine Platform to Improve Cancer Treatment Outcomes Business Wire

Oct 6, 2021

07:33AM EDT The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal Benzinga

Oct 5, 2021

04:01PM EDT Exscientia Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters' Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement Business Wire

08:01AM EDT The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout Benzinga

Oct 1, 2021

11:33AM EDT Exscientia Shares Open For Trade At $27.14; IPO Priced At $22/ADS Benzinga

09:11AM EDT Exscientia Shares Will Open For Quote At 10:10 a.m. EDT, Expected To Open For Trade After 10:20 a.m. EDT; IPO Priced At $22/ADS Benzinga

07:56AM EDT The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO Benzinga

Sep 30, 2021

09:52PM EDT Exscientia Announces Pricing of $304.7 Million Upsized Initial Public Offering and $160.0 Million Concurrent Private Placements Business Wire

Jul 15, 2021

09:03AM EDT Expert.ai Announces Winners of Sentiment & Opinion Mining Hackathon PR Newswire

Share